Faruqi & Faruqi, LLP is Seeking More Cash for the Shareholders of Coventry Health Care, Inc. (CVH)
Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of Coventry Health Care, Inc. (“Coventry” or the “Company”) (NYSE: CVH) for potential breaches of fiduciary duties in connection with their conduct related to the sale of the Company to Aetna Inc. (“Aetna”) (NYSE: AET) in a cash-and-stock deal valued at approximately $7.3 billion. Under the terms of the proposed transaction, Coventry stockholders will receive $27.30 in cash and 0.3885 Aetna common shares for each Coventry share they own. The agreement values the proposed consideration at approximately $42.08 per share, based on the closing price of Aetna common shares on Friday, August 17, 2012.
Whether Coventry’s Board of Directors breached their fiduciary duties to the Company’s stockholders by failing to conduct an adequate and fair sales process prior to agreeing to this proposed transaction, whether the proposed transaction undervalues Coventry’s shares and by how much this proposed transaction undervalues the Company to the detriment of Coventry’s shareholders are the key focus of this investigation.
If you own common stock in Coventry and wish to obtain additional information and protect your investments free of charge, please contact Juan E. Monteverde, Esq. either via e-mail at email@example.com or by telephone at (877) 247-4292 or (212) 983-9330.
Please tell us about yourself by completing the form below and we will provide you with additional
information at no cost to you on how to join the Class Action.
* The submission of this form does not create an attorney-client relationship.
Faruqi & Faruqi, LLP
685 Third Avenue 26th Floor
New York, NY 10017
Tel: (212) 983-9330
If you have information regarding this case that you would like to make available, please click here to contact us about our investigation.